Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Multiple Sclerosis l: Introduction01:19

Multiple Sclerosis l: Introduction

Multiple sclerosis is a chronic autoimmune disease of the central nervous system (CNS) that affects the brain, spinal cord, and optic nerves. It is an inflammatory demyelinating disorder and a leading cause of neurological disability in young adults.EpidemiologyMS commonly begins between 20 and 40 years of age and is twice as common in women. Its exact cause remains unclear, but genetic susceptibility contributes, with higher risk in first-degree relatives and identical twins. A greater...
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation01:21

Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation

Clinical manifestationsPeripheral Arterial Disease (PAD) manifests through a range of symptoms, from the characteristic intermittent claudication to atypical presentations and severe complications in advanced stages. Intermittent claudication, a hallmark symptom of PAD, presents as exercise-induced muscle pain that typically resolves within minutes of rest. This pain is reproducible and stems from inadequate blood flow, leading to the accumulation of lactic acid produced during anaerobic...
Secondary Spinal Cord Injury llI: Pathophysiology01:25

Secondary Spinal Cord Injury llI: Pathophysiology

Early Ischemia and Ionic ImbalanceWithin minutes of spinal cord injury, a secondary cascade begins, progressing over hours to weeks. Vascular damage reduces blood flow, causing ischemia and mitochondrial dysfunction. ATP depletion leads to ion pump failure, membrane depolarization, sodium influx, potassium efflux, and water accumulation, resulting in cellular swelling. Increased intracellular calcium further disrupts mitochondria and accelerates cellular injury.Excitotoxicity and Neuronal...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

<i>KMT2B</i>-related disorders: expansion of the phenotypic spectrum and long-term efficacy of deep brain stimulation.

ArXiv·2025
Same author

The episodic ataxias.

Handbook of clinical neurology·2024
Same author

Pain-Related Vertex Evoked Potentials. Comparison of Surface Electrical to Heat Stimulation.

Journal of clinical neurophysiology : official publication of the American Electroencephalographic Society·2023
Same author

Correction to: Episodic Ataxia Type 1: Natural History and Effect on Quality of Life.

Cerebellum (London, England)·2022
Same author

Episodic Ataxia Type 1: Natural History and Effect on Quality of Life.

Cerebellum (London, England)·2022
Same author

Research priorities for mitochondrial disorders: Current landscape and patient and professional views.

Journal of inherited metabolic disease·2022

Related Experiment Video

Updated: Jun 2, 2026

Three-dimensional Imaging of Nociceptive Intraepidermal Nerve Fibers in Human Skin Biopsies
11:22

Three-dimensional Imaging of Nociceptive Intraepidermal Nerve Fibers in Human Skin Biopsies

Published on: April 29, 2013

SCA3 presenting as an isolated axonal polyneuropathy.

Tracey D Graves1, Roberto J Guiloff

  • 1Neuromuscular Unit, West London Neurosciences Centre, Imperial College Healthcare NHS Trust, Charing Cross Hospital, Fulham Palace Road, London, United Kingdom.

Archives of Neurology
|May 11, 2011
PubMed
Summary
This summary is machine-generated.

Spinocerebellar ataxia type 3 (SCA3) can initially present as an isolated axonal polyneuropathy. This rare presentation highlights the diverse clinical spectrum of SCA3, emphasizing the need for genetic testing.

More Related Videos

A Simple Composite Phenotype Scoring System for Evaluating Mouse Models of Cerebellar Ataxia
07:33

A Simple Composite Phenotype Scoring System for Evaluating Mouse Models of Cerebellar Ataxia

Published on: May 21, 2010

Related Experiment Videos

Last Updated: Jun 2, 2026

Three-dimensional Imaging of Nociceptive Intraepidermal Nerve Fibers in Human Skin Biopsies
11:22

Three-dimensional Imaging of Nociceptive Intraepidermal Nerve Fibers in Human Skin Biopsies

Published on: April 29, 2013

A Simple Composite Phenotype Scoring System for Evaluating Mouse Models of Cerebellar Ataxia
07:33

A Simple Composite Phenotype Scoring System for Evaluating Mouse Models of Cerebellar Ataxia

Published on: May 21, 2010

Area of Science:

  • Neurogenetics
  • Neurology
  • Clinical Medicine

Background:

  • Spinocerebellar ataxia type 3 (SCA3), also known as Machado-Joseph disease, is an autosomal dominant neurodegenerative disorder.
  • It is characterized by progressive cerebellar ataxia, but extraneurological and atypical neurological manifestations are increasingly recognized.

Observation:

  • A middle-aged man with no family history of SCA3 presented with a 6-year history of isolated axonal, distal, symmetric, sensorimotor polyneuropathy.
  • This neuropathy preceded the development of a classic cerebellar syndrome.

Findings:

  • The patient's presentation mimicked common peripheral neuropathies for an extended period.
  • Genetic testing confirmed SCA3, revealing an unusual initial phenotype.

Implications:

  • This case underscores that SCA3 should be considered in the differential diagnosis of isolated axonal polyneuropathy, even without a family history.
  • Recognizing atypical presentations is crucial for timely diagnosis and management of SCA3.